Concepedia

Robert W. Ross

RW

Statistics

Publications

44

Citations

16.1K

H-Index

32

Active since

1947

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Memorial Sloan Kettering Cancer Center

Beth Israel Deaconess Medical Center

Robert W. Ross is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and prostate cancer.

Publications per year

1947–2020

44

Publications

44

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

Medicine, Oncology, Pharmacology +15

Gene Therapy in a Patient with Sickle Cell Disease

Jean‐Antoine Ribeil, Salima Hacein‐Bey‐Abina, Emmanuel Payen et al. · New England Journal of Medicine · 2017 · 669 citations · Full text

Medicine, Genetics, Hematology +17

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Alexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski et al. · New England Journal of Medicine · 2018 · 661 citations · Full text

Medicine, Genetics, Hematology +16

Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

Toni K. Choueiri, Ulka N. Vaishampayan, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology · 2012 · 458 citations · Full text

Medicine, Oncology, Pharmacology +17

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

Lecia V. Sequist, Scott Gettinger, Neil Senzer et al. · Journal of Clinical Oncology · 2010 · 331 citations

Medicine, Oncology, Pharmacology +16

1–5 of 44